|
CD24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.776800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.131600E-01 |
| Normal-vs-Stage2 |
4.256600E-01 |
| Normal-vs-Stage3 |
9.151200E-01 |
| Normal-vs-Stage4 |
8.072200E-01 |
| Stage1-vs-Stage2 |
8.490800E-01 |
| Stage1-vs-Stage3 |
1.620410E-01 |
| Stage1-vs-Stage4 |
1.697640E-01 |
| Stage2-vs-Stage3 |
4.290400E-01 |
| Stage2-vs-Stage4 |
3.794400E-01 |
| Stage3-vs-Stage4 |
7.255000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.755400E-01 |
| Normal-vs-AfricanAmerican |
6.401400E-01 |
| Normal-vs-Asian |
6.784400E-01 |
| Caucasian-vs-AfricanAmerican |
9.564800E-01 |
| Caucasian-vs-Asian |
7.762600E-01 |
| AfricanAmerican-vs-Asian |
7.477800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.369800E-01 |
| Normal-vs-Female |
1.618770E-01 |
| Male-vs-Female |
1.172640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.031400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.817000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.865200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.473000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.687600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.585600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.792400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.791600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.545600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.107000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.321200E-01 |
| Normal-vs-Grade 2 |
1.441820E-01 |
| Normal-vs-Grade 3 |
4.429000E-01 |
| Normal-vs-Grade 4 |
3.319900E-02 |
| Grade 1-vs-Grade 2 |
4.225800E-01 |
| Grade 1-vs-Grade 3 |
2.561400E-01 |
| Grade 1-vs-Grade 4 |
5.066100E-02 |
| Grade 2-vs-Grade 3 |
3.413600E-01 |
| Grade 2-vs-Grade 4 |
4.32510000000219E-05 |
| Grade 3-vs-Grade 4 |
2.258200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.114300E-02 |
| Normal-vs-ccB subtype |
5.846600E-01 |
| ccA subtype-vs-ccB subtype |
1.902390E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.024000E-01 |
| Normal-vs-N1 |
7.130800E-01 |
| N0-vs-N1 |
3.242800E-01 |
|
|
